Whitehawk Therapeutics (WHWK) Long-Term Debt Issuances (2010 - 2017)
Whitehawk Therapeutics (WHWK) reported Long-Term Debt Issuances of $297354.0 for Q1 2017, down 91.43% on a QoQ basis from $3.5 million in Q4 2016.
Whitehawk Therapeutics (WHWK) has 6 years of Long-Term Debt Issuances data on file, last reported at $297354.0 in Q1 2017.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $297354.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $297354.0 (down 96.29% YoY) and the FY2017 annual result came in at $297354.0, down 97.63% from the prior year.
- Long-Term Debt Issuances declined to $297354.0 in Q1 2017 per WHWK's latest filing, from $3.5 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $4.5 million in Q3 2016 and bottomed at $15000.0 in Q4 2015.
- The 4-year median for Long-Term Debt Issuances is $161177.0 (2013), against an average of $1.4 million.
- Peak annual rise in Long-Term Debt Issuances reached 23027.61% in 2016, while the deepest fall reached 23027.61% in 2016.
- Tracing WHWK's Long-Term Debt Issuances over 4 years: stood at $25000.0 in 2013, then slumped by 40.0% to $15000.0 in 2015, then soared by 23027.61% to $3.5 million in 2016, then plunged by 91.43% to $297354.0 in 2017.
- Per Business Quant, the three latest WHWK Long-Term Debt Issuances figures stand at $297354.0 (Q1 2017), $3.5 million (Q4 2016), and $4.5 million (Q3 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 297,354.00 |
| Mar 31, 2017 | 297,354.00 |
| Dec 31, 2016 | 3.47 Mn |
| Dec 31, 2016 | 3.47 Mn |
| Sep 30, 2016 | 4.54 Mn |
| Sep 30, 2016 | 4.54 Mn |
| Dec 31, 2015 | 15,000.00 |
| Dec 31, 2015 | 15,000.00 |
| Mar 31, 2015 | 20,000.00 |
| Mar 31, 2015 | 20,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |